Iovance Biotherapeutics, Inc. (IOVA)

Iovance Biotherapeutics, Inc. (IOVA) is a healthcare company (biotechnology) based in the United States. The share price is $7.53, down 0.26% on the day, which values the company at $3.48B. Price as of 18 Nov 2026, 10:38 UTC, from Yahoo Finance.

Key facts

Share price
$7.53−0.26% today
Market value
$3.48B
200-week average
$6.3818% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Iovance Biotherapeutics, Inc. in more detail

IOVA trades at -66.1× next year's expected earnings, 9.2× sales. It sits 18% above its 200-week average of $6.38.

In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

Iovance Biotherapeutics, Inc. (IOVA): questions and answers

What is Iovance Biotherapeutics, Inc.'s market cap?

Iovance Biotherapeutics, Inc. is valued at $3.48B at a share price of $7.53.

Is IOVA above its 200-week moving average?

Yes. IOVA is 18.1% above its 200-week average of $6.38. Long-term investors watch that line because strong companies rarely trade below it for long.

Does IOVA pay a dividend?

Iovance Biotherapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Iovance Biotherapeutics, Inc. (IOVA) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/IOVA

Underlying data: Yahoo Finance; company filings with the SEC.